Company Overview
Diversified Healthcare Trust operates as a real estate investment trust dedicated to acquiring and managing high-quality healthcare properties located throughout the United States, aiming to provide diversification across the health services spectrum by care delivery and practice type. The company functions within the Real Estate sector, specifically the REIT - Healthcare Facilities industry, a classification that dictates its distribution requirements and tax-advantaged structure for property owners. This entity manages a significant asset base with a total market capitalization of $1.63B and generates annual revenue reaching $1.54B, though specific employee count data is not disclosed in available filings. The scale indicated by a market cap of $1.63B and revenue of $1.54B suggests the company holds a substantial footprint in the specialized healthcare real estate market, positioning it as a major player relative to smaller regional property trusts.
Financial Health
The company reported trailing twelve-month revenue of $1.54B alongside a net income of $-285,886,016, while maintaining an EBITDA of $222.77M. The substantial gap between the $1.54B in revenue and the negative net income of approximately $286M reveals a cost structure where operating expenses and interest charges significantly erode bottom-line profitability despite strong operational cash generation. Despite the reported net loss, the entity maintains a robust free cash flow of $445.83M, which indicates a high degree of financial flexibility to service debt obligations and fund capital improvements without relying on external equity financing. When analyzing profitability metrics, the gross margin stands at 17.4%, while the operating margin is negative at -2.9% and the profit margin is negative at -18.6%, suggesting that while property-level economics are viable, overhead costs and financing expenses are consuming a large portion of the gross proceeds. The balance sheet shows a cash position of $105.41M against total debt of $2.42B, resulting in a debt-to-equity ratio of 145.16, which characterizes the entity as highly leveraged given the magnitude of debt relative to equity. Short-term liquidity appears secure with a current ratio of 6.08, indicating that the company holds more than six times the liquid assets necessary to cover its immediate current liabilities. Return on Equity is reported at -15.8% and Return on Assets at -0.5%, metrics that reveal management is currently struggling to generate returns on shareholder capital and asset bases due to the significant net loss impacting the equity base.
Valuation Assessment
The valuation profile presents a trailing P/E ratio of N/A due to the negative earnings, while the forward P/E is listed at -15.63, implying that the market is currently pricing in future earnings expectations that remain negative or are not yet realized. The price-to-book ratio stands at 0.98, indicating that the market values the company at a slight discount to its net asset book value rather than applying a premium for its growth potential or asset quality. Alternative valuation metrics such as the price-to-sales ratio of 1.06 and an EV/EBITDA of 17.68 provide different perspectives, suggesting the company trades at a dollar-for-dollar multiple of sales and a premium multiple of earnings before interest, taxes, depreciation, and amortization. The stock price has fluctuated significantly within a 52-week range bounded by a high of $7.66 and a low of $2.00, meaning the current trading price sits within this wide volatility band but the specific percentage distance from the high or low is not calculable without the precise current share price. The beta value of 2.39 indicates that the stock price is highly volatile and typically moves with much greater magnitude than the broader market index, reflecting the inherent risks associated with healthcare real estate and interest rate sensitivity.
Growth & Income
Revenue growth year-over-year is recorded at 0.0%, while earnings growth year-over-year is N/A due to the negative net income, implying that the company is currently in a phase of consolidation or restructuring rather than expansion. The company pays a dividend with a yield of 0.6% and a payout ratio of 2.3%, which is technically sustainable mathematically but represents a minimal return relative to the capital invested and the high leverage on the balance sheet. Given the negative net income of $-285,886,016, the payout ratio suggests the dividend is being paid from free cash flow or reserves rather than distributable earnings, a common practice for REITs facing temporary operational headwinds. The overall growth and income profile is defined by static revenue, significant leverage, and a low-yield dividend that does not compensate for the high beta volatility of 2.39.